ZIVO Bioscience Statistics
Total Valuation
ZIVO has a market cap or net worth of $22.50 million. The enterprise value is $22.57 million.
| Market Cap | 22.50M |
| Enterprise Value | 22.57M |
Important Dates
The last earnings date was Monday, November 13, 2023, after market close.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ZIVO has 2.78 million shares outstanding.
| Shares Outstanding | 2.78M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.58% |
| Owned by Institutions (%) | 0.08% |
| Float | 1.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 813.70 |
| Forward PS | 232.19 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 816.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,399.49% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $3,456 |
| Profits Per Employee | -$972,148 |
| Employee Count | 8 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -44,040 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.05% in the last 52 weeks. The beta is 0.27, so ZIVO's price volatility has been lower than the market average.
| Beta (1Y) | 0.27 |
| 52-Week Price Change | -53.05% |
| 50-Day Moving Average | 8.19 |
| 200-Day Moving Average | 6.89 |
| Relative Strength Index (RSI) | 51.21 |
| Average Volume (30 Days) | 2,517 |
Short Selling Information
The latest short interest is 35,465, so 1.28% of the outstanding shares have been sold short.
| Short Interest | 35,465 |
| Short Previous Month | 161,326 |
| Short % of Shares Out | 1.28% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 6.65 |
Income Statement
In the last 12 months, ZIVO had revenue of $27,650 and -$7.78 million in losses. Loss per share was -$3.63.
| Revenue | 27,650 |
| Gross Profit | 11,610 |
| Operating Income | -7.26M |
| Pretax Income | -7.78M |
| Net Income | -7.78M |
| EBITDA | -7.26M |
| EBIT | -6.99M |
| Loss Per Share | -$3.63 |
Balance Sheet
The company has $274,380 in cash and $346,342 in debt, giving a net cash position of -$71,962 or -$0.03 per share.
| Cash & Cash Equivalents | 274,380 |
| Total Debt | 346,342 |
| Net Cash | -71,962 |
| Net Cash Per Share | -$0.03 |
| Equity / Book Value | -2.21M |
| Book Value Per Share | -0.79 |
| Working Capital | -2.34M |
Cash Flow
| Operating Cash Flow | -5.80M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.80M |
| FCF Per Share | -$2.09 |
Margins
Gross margin is 41.99%, with operating and profit margins of -26,267.68% and -28,127.24%.
| Gross Margin | 41.99% |
| Operating Margin | -26,267.68% |
| Pretax Margin | -28,127.24% |
| Profit Margin | -28,127.24% |
| EBITDA Margin | -26,267.68% |
| EBIT Margin | -25,290.33% |
| FCF Margin | -20,976.10% |
Dividends & Yields
ZIVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -34.57% |
| FCF Yield | -25.78% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 27, 2023. It was a reverse split with a ratio of 1:6.
| Last Split Date | Oct 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
ZIVO has an Altman Z-Score of -352.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -352.97 |
| Piotroski F-Score | 1 |